3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
6
Gastrointestinal
6
Endocrine
6
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Head & Neck
1
Genitourinary
1
Breast
1
Conditions
Sarcoma
163
Osteosarcoma
56
Gastrointestinal Stromal Tumors
40
Bone Neoplasms
32
Glioblastoma
22
Gliosarcoma
21
Sarcoma, Ewing
20
Dendritic Cell Sarcoma, Interdigitating
20
Lymphoma
19
Brain Neoplasms
18
Neoplasms
17
Central Nervous System Neoplasms
17
Stomach Neoplasms
16
Breast Neoplasms
16
Ovarian Neoplasms
15
Leiomyosarcoma
15
Rhabdomyosarcoma
13
Neuroblastoma
13
Neoplasm Metastasis
13
Recurrence
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Pancreatic Neoplasms
12
Liposarcoma
12
Astrocytoma
12
Esophageal Neoplasms
11
Chondrosarcoma
11
Burkitt Lymphoma
11
Sarcoma, Synovial
10
Oligodendroglioma
9
Neurofibrosarcoma
9
Interventions
regorafenib
1
Clinical Trials, Phase II as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Gastro-enteropancreatic neuroendocrine tumor
×
Sarcoma
×
Clear all
NCT03475953
2023-03-03
REGOMUNE
Institut Bergonié
Phase 1/2
Unknown
747 enrolled